Securities Code: 002390 Securities Abbreviation: Baiyun Pharmaceutical Announcement Number: 2026-017 Guizhou Baiyun Pharmaceutical Co., Ltd. 2025 Annual Equity Distribution Implementation Announcement The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or significant omissions.
Special Notice:
- In accordance with the "Company Law of the People's Republic of China," "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 9—Share Repurchase," and other relevant regulations, Guizhou Baiyun Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") will not participate in this equity distribution with the 47,445,540 shares held in its dedicated securities account for share repurchase. The Company's 2025 annual equity distribution plan is as follows: based on the total share capital of 1,943,851,868 shares, minus the 47,445,540 shares repurchased by the Company's dedicated securities account for share repurchase, resulting in a share capital of 1,896,406,328 shares. A cash dividend of RMB 0.60 (tax inclusive) per 10 shares will be distributed to all shareholders, totaling RMB 113,784,379.68. No bonus shares will be issued, and no capital reserve will be transferred to share capital.
- When calculating the ex-rights and ex-dividend price after the implementation of this equity distribution, the cash dividend per 10 shares (tax inclusive) calculated based on the total share capital (including the number of shares held in the Company's dedicated securities account for share repurchase) is calculated as: Total cash dividend ÷ Total share capital × 10 = RMB 113,784,379.68 / 1,943,851,868 shares × 10 shares = RMB 0.585355 per 10 shares (retaining six decimal places, truncating the last digit, no rounding). The ex-rights and ex-dividend reference price after the implementation of this equity distribution = (Closing price of the trading day before ex-rights and ex-dividend – cash dividend per share calculated based on total share capital) / (1 + ratio of capital reserve transferred to share capital calculated based on total share capital) = (Closing price of the trading day before ex-rights and ex-dividend – RMB 0.0585355 per share) / (1 + 0).
Guizhou Baiyun Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") announces that its 2025 annual equity distribution plan was approved at the 2025 Annual General Meeting held on May 12, 2026. The matters concerning the equity distribution are hereby announced as follows: